Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 7, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • The disparity in auxin regulation role by GRAIN WEIGHT GENES in developing grains

Estimation of Nitrogen and Chlorophyll Content in Tea Leaves

Chemotaxis – Driven 2D Nanosheet for drug delivery

The disparity in auxin regulation role by GRAIN WEIGHT GENES in developing grains
  • BiotechToday
  • World

The disparity in auxin regulation role by GRAIN WEIGHT GENES in developing grains

bioxone October 17, 2020October 17, 2020

–Rohit Bhattacharjee, Amity University, Kolkata.

The wheat and rice THOUSAND GRAIN WEIGHT 6 genes (TaTGW6 and OsTGW6, respectively) are reported in larger wheat and rice grains which are formed by reducing Indole-3-acetic acid (IAA) production in developing grains. Although, a critical comparison of data on TaTGW6 and OsTGW6 with other reports on auxin synthesis in grains requires the hypothesis to be reinvestigated. This study reports that TaTGW6 and OsTGW6 are members of large gene families that have undergone major, lineage-specific gene expansion. Wheat has 9 genes and rice has 3 genes encoding for proteins with more than 80% amino acid identity with TGW6, making it difficult to contemplate how a single inactive allele could have a major effect on IAA levels. TGW6 is proposed to affect auxin levels by catalysing the IAA-glucose (IAA-Glc) hydrolysis.

Previous works on TGW6 showed maximal expression at 20 days after anthesis (DAA) in wheat and 2 DAA in rice. However, it was shown that neither of the genes was expressed in developing grains. Rather, TaTGW6, OsTGW6, and their close homologues are exclusively expressed in pre-emergence inflorescences. TaTGW6 is particularly expressed in microspores before mitosis. This combined with evidence for high IAA production levels from tryptophan in developing grain demonstrates TaTGW6 and OsTGW6 cannot regulate grain size via IAA-Glc hydrolysis. Instead, their similarity to rice strictosidine synthase-like 2 (OsSTRL2) indicates that they play a key role in pollen development.

Also read: Non-antimicrobials as Antibiotics: Wonder of Drug Repurposing

Source:- 

  1. https://www.biorxiv.org/content/10.1101/2020.10.14.340042v1
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged auxin grain weight IAA-Glc OsSTRL2 TGW6 wheat

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Chemotaxis – Driven 2D Nanosheet for drug delivery

bioxone October 17, 2020

Saptaparna Pal, Amity University Kolkata Nano sealed motor particles represents a group of efficient molecules that can precisely respond to the biological microenvironment and improves therapeutic results. Hence, a 2D nanosheet based catalytic nanometre with chemotaxis behaviour is designed for enhanced and advanced drug delivery towards the Tumor microenvironment. The 2D structure of nanometre allows […]

drug delivery

Related Post

  • BiotechToday
  • World

Mitral Valve Replacement in children and infants

BioTech Today July 29, 2021July 29, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University ‘Lub-Dub’ is the sound the heart makes every time it beats. It is probably one of the most easily recognizable sounds. The heart is one of the most essential organs in the body, pumping blood to all the parts of the body. It is required to transport […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • India
  • Latest

COVID UPDATE: Russian Covid-19 vaccine Phase 3 trials to start in India this month, Preliminary Results by November

bioxone September 7, 2020September 7, 2020

–Sayak Biswas, Amity University Kolkata When the world is trying to fight through the Covid-19 pandemic, Scientists and Researchers are silently working to develop vaccines which can lead to some relief. There are currently a huge number of vaccines under developed for Covid-19. One among them is the Russian vaccine Sputnik V. The Russian vaccine […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Gene therapy clinical trials for rare Angelman syndrome put on hold

bioxone November 7, 2020November 6, 2020

Surupa Chakraborty, Amity University Kolkata A new gene therapy clinical trial for treating Angelman syndrome has been put to hold after two candidates temporarily lost their ability to walk. GTX102, the drug used in the clinical trial was developed by a California-based biopharmaceutical company Ultragenyx, in collaboration with GeneTx, a Florida-based biotech startup. The trial […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy